| scholarly article | Q13442814 |
| P50 | author | Sarah Cobey | Q56072288 |
| P2093 | author name string | Joseph A Lewnard | |
| P2860 | cites work | Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine | Q72145722 |
| Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection | Q85094818 | ||
| Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011-2012, 2012-2013, and 2013-2014 Influenza Seasons | Q88024686 | ||
| Rapid cloning of high-affinity human monoclonal antibodies against influenza virus | Q24644672 | ||
| Antibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses | Q27312311 | ||
| Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015. | Q30151372 | ||
| Cytomegalovirus infection enhances the immune response to influenza. | Q30300254 | ||
| Impact of influenza vaccination on seasonal mortality in the US elderly population. | Q30350187 | ||
| Immune history shapes specificity of pandemic H1N1 influenza antibody responses. | Q30352126 | ||
| Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. | Q30352862 | ||
| Sex-based biology and the rational design of influenza vaccination strategies. | Q30363998 | ||
| Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated | Q30381731 | ||
| Immune history profoundly affects broadly protective B cell responses to influenza. | Q30382131 | ||
| Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. | Q30383312 | ||
| Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
| Effect of Statin Use on Influenza Vaccine Effectiveness | Q30391150 | ||
| Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13. | Q51151777 | ||
| The case test-negative design for studies of the effectiveness of influenza vaccine. | Q51225150 | ||
| "Gnothi Seauton": Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy. | Q52381548 | ||
| Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies. | Q52602393 | ||
| RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN". | Q54146440 | ||
| A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. | Q54262077 | ||
| Vaccines for preventing influenza in healthy adults | Q56603717 | ||
| Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies | Q56983373 | ||
| Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine | Q57061672 | ||
| Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. | Q30391675 | ||
| Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting | Q30395224 | ||
| Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong | Q30396064 | ||
| Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 | ||
| Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. | Q30398762 | ||
| MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines | Q30403361 | ||
| Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase | Q30425783 | ||
| Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data | Q30903230 | ||
| Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
| Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China | Q34350881 | ||
| Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
| Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season | Q34480810 | ||
| Antibody landscapes after influenza virus infection or vaccination. | Q34580640 | ||
| Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | Q34783486 | ||
| Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study | Q35217987 | ||
| Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
| Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials | Q35870576 | ||
| Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers | Q35887557 | ||
| Strategies to alleviate original antigenic sin responses to influenza viruses | Q36187304 | ||
| Antibody response to influenza vaccination in the elderly: a quantitative review | Q36280602 | ||
| A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants | Q36389642 | ||
| Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans | Q36496580 | ||
| Variable efficacy of repeated annual influenza vaccination | Q36705674 | ||
| Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness | Q36705828 | ||
| Influenza vaccine effectiveness in the community and the household | Q36956943 | ||
| A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season | Q36991782 | ||
| The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings | Q37260000 | ||
| Direct and indirect effects in vaccine efficacy and effectiveness | Q37322067 | ||
| Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. | Q38406947 | ||
| 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type | Q38410159 | ||
| Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
| The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
| Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses | Q38607708 | ||
| The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis | Q38639994 | ||
| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
| Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies | Q38907201 | ||
| Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. | Q38957414 | ||
| Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence | Q39027310 | ||
| Immune history and influenza virus susceptibility | Q39088963 | ||
| Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera | Q39215322 | ||
| Repeated annual influenza vaccination and vaccine effectiveness: review of evidence | Q39340731 | ||
| Estimating Influenza Vaccine Effectiveness in the Test-negative Design Using Alternative Control Groups - a Systematic Review and Meta-analysis | Q39391746 | ||
| Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. | Q39418099 | ||
| Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness | Q39429254 | ||
| Increased risk of influenza among vaccinated adults who are obese | Q40184119 | ||
| Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. | Q40670577 | ||
| Invited Commentary: Beware the Test-Negative Design | Q41031858 | ||
| Predetermination by infection and by vaccination of antibody response to influenza virus vaccines | Q41570161 | ||
| A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine | Q41831623 | ||
| The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine | Q41919202 | ||
| Seeking help: B cells adapting to flu variability | Q42201392 | ||
| Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine | Q42242172 | ||
| Selection of controls in case-control studies. II. Types of controls | Q43881538 | ||
| Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence | Q44551905 | ||
| The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder | Q45254227 | ||
| Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period | Q45760959 | ||
| Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
| The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection | Q46221254 | ||
| Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. | Q47150783 | ||
| A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination | Q47162930 | ||
| The Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis and Meta-regression of Test-Negative Design Case-control Studies. | Q47343143 | ||
| Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States | Q47549841 | ||
| Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires | Q47552319 | ||
| Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic | Q47552843 | ||
| Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada | Q47613621 | ||
| Vaccines for preventing influenza in healthy children | Q47638511 | ||
| Vaccines for preventing influenza in the elderly. | Q47641366 | ||
| On the bias of estimates of influenza vaccine effectiveness from test-negative studies | Q47709222 | ||
| Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. | Q49981002 | ||
| Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015. | Q50041580 | ||
| Waxing Understanding of Waning Immunity | Q50211524 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| influenza vaccine | Q383260 | ||
| P304 | page(s) | 28 | |
| P577 | publication date | 2018-05-21 | |
| P1433 | published in | Vaccines | Q27725508 |
| P1476 | title | Immune History and Influenza Vaccine Effectiveness | |
| P478 | volume | 6 |
| Q64251725 | Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections |
| Q63246475 | Can We Improve Vaccine Efficacy by Targeting T and B Cell Repertoire Convergence? |
| Q92124090 | Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics |
| Q94458554 | Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross |
| Q99595731 | Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review |
| Q89759208 | Early prediction of antigenic transitions for influenza A/H3N2 |
| Q98578103 | Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine |
| Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
| Q90062026 | Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection |
| Q92652747 | Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population |
| Q92822357 | Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults |
| Q93038069 | Influenza in Latin America: A report from the Global Influenza Initiative (GII) |
| Q103825192 | Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness |
| Q91652152 | Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort |
| Q59354719 | Measurement of Vaccine Direct Effects under the Test-Negative Design |
| Q91976049 | Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines |
| Q92940684 | New Rabies Vaccines for Use in Humans |
| Q89723360 | Next-generation influenza vaccines: opportunities and challenges |
| Q64116962 | Novel Approaches for The Development of Live Attenuated Influenza Vaccines |
| Q92547217 | Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses |
| Q89993503 | Original Antigenic Sin and Respiratory Syncytial Virus Vaccines |
| Q91941703 | Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets |
| Q59357667 | The Effects of Birth Year, Age and Sex on Hemagglutination Inhibition Antibody Responses to Influenza Vaccination |
| Q90680212 | Toosendanin From Melia Fructus Suppresses Influenza A Virus Infection by Altering Nuclear Localization of Viral Polymerase PA Protein |
| Q90232087 | Vaccine literacy is undervalued |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
Search more.